A Year After ‘Pivot To Growth’, Teva Keeps Pushing Forward With Innovative Assets

Firm Highlights LAI Olanzapine, As Trial Results Come Nine Months Ahead Of Schedule

 
• By Dave Wallace
  
Finger pushing innovation button
Another of Teva’s innovative assets has delivered results • Source: Shutterstock

More from Products

More from Generics Bulletin